News & Events

The latest items of interest from RareCyte

Seattle, WA, August 24, 2017 – RareCyte, Inc., a global rare cell detection and liquid biopsy company will use the funding to advance its commercial sales efforts and build companion diagnostics (CDx) programs with strategic partners. The Company will also expand its regulatory infrastructure and research and development efforts. The $30M investment was led by 5AM Ventures with participation from existing investors Telegraph Hill Partners (THP), founder Ron Seubert and other investors. Read more

Interested in learning more?

Complete the form below and we will get in touch with you to discuss any questions you may have about the company, the products or applications of RareCyte technology.